Publications
Integrated analysis of key differentially expressed genes identifies DBN1 as a predictive marker of response to endocrine therapy in luminal breast cancer
Institution: University of Nottingham Biodiscovery Institute
Keyword(s): DBN1, oestrogen receptor, endocrine resistance, predictive biomarker
Summary: Endocrine therapy is the mainstay of adjuvant treatment for patients with luminal breast cancer. Despite ongoing advances in endocrine therapy to date, a proportion of patients...
Year: 2020
Publications
Macrophages induce malignant traits in mammary epithelium via IKKε/TBK1 kinases and the serine biosynthesis pathway
Institution: Barts Cancer Institute, Queen Mary University of London
Keyword(s): IHC quantification, obesity, ikkε, macrophages, inflammation
Summary: During obesity, macrophages infiltrate the breast tissue leading to low-grade chronic inflammation, a factor considered responsible for the higher risk of breast cancer associat...
Year: 2020
Publications
PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression
Institution: School of Life Sciences, University of Sussex
Keyword(s): triple negative breast cancer, cell biology, protein kinases, signal transduction, fibroblasts, PIK3Cδ
Summary: As there is growing evidence for the tumor microenvironment's role in tumorigenesis, we investigated the role of fibroblast-expressed kinases in triple-negative breast cancer (T...
Year: 2020
Publications
PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer
Institution: University of Nottingham Biodiscovery Institute
Keyword(s): endocrine resistance, liprin, oestrogen receptor, PPFIA1, predictive biomarker
Summary: BACKGROUND. PPFIA1 is an important regulator of cell migration and invasion, regulating focal adhesion signalling and disassembly. PPFIA1 is frequently amplified in breast cance...
Year: 2020
Publications
Pin1 plays a key role in the response to treatment and clinical outcome in triple negative breast cancer
Institution: School of Pharmacy, Queen's University Belfast
Keyword(s): BRCA1, Pin1, biomarker, chemotherapy, triple negative breast cancer
Summary: BACKGROUND. Triple negative breast cancer (TNBC) is the subset of breast cancer associated with the poorest outcome, and currently lacks targeted treatments. Standard of care (S...
Year: 2020
Publications
SOX11 promotes epithelial/mesenchymal hybrid state and alters tropism of invasive breast cancer cells
Institution: Institute of Cancer Research
Keyword(s): ductal carcinoma in situ, MEX3A, SOX11, cancer biology, developmental biology
Summary: SOX11 is an embryonic mammary epithelial marker that is normally silenced prior to birth. High SOX11 levels in breast tumours are significantly associated with distant metastasi...
Year: 2020
Publications
Subcellular mRNA localization regulates ribosome biogenesis in migrating cells
Institution: Barts Cancer Institute, Queen Mary University of London
Keyword(s): IHC, RNA localization, ribosome biogenesis, La-related proteins, EMT, LARP6
Summary: Translation of ribosomal protein-coding mRNAs (RP-mRNAs) constitutes a key step in ribosome biogenesis, but the mechanisms that modulate RP-mRNA translation in coordination with...
Year: 2020
Publications
The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ
Institution: University of Nottingham Biodiscovery Institute
Keyword(s): -
Summary: BACKGROUND. Oestrogen receptor (ER) in invasive breast cancer (BC) predicts response to endocrine therapy (ET) and provides prognostic value. In this study, we investigated the...
Year: 2020
Publications
The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma
Institution: Peter MacCallum Cancer Centre; University of Melbourne
Keyword(s): genomics, intraductal papillomas, progression, PIK3CA
Summary: Intraductal papillomas (IDP) are challenging breast findings because of their variable risk of progression to malignancy. The molecular events driving IDP development and genomi...
Year: 2020